Phthisis Diagnostics Introduces First Product to Pathology Market
Product News Sep 13, 2011
Phthisis Diagnostics will introduce the company’s first product to the pathology market at the College of American Pathologists 2011 annual meeting: CAP ‘11 - THE Pathologists’ Meeting™ to be held September 11-14 in the Dallas/Ft. Worth area.
Phthisis Diagnostics, based in Charlottesville, VA, triggered strong market interest in previous laboratory and microbiology exhibitions over the summer.
The company’s initial product, the E-Sphere® Stool DNA Extraction Kit, is the first in a planned series of products under development for the Phthisis Diagnostics’ Simply Molecular® catalogue and slated for release over the next two years.
This first kit is a uniquely efficient way to extract DNA from stool samples and a major improvement over competing processes. It takes only nine steps instead of 32; requires only two sample transfers, reducing potential contamination risks; and it processes 12 samples in 30 minutes instead of in two hours.
Results are more accurate and there is less waste material for laboratory disposal. The increased workflow efficiency and productivity for laboratories means significant potential cost savings and greater capacity.
The product’s ability to produce high quality DNA in a cost effective way makes it an ideal first step for a number of other companies’ diagnostic tests.
As part of the product launch, Phthisis President Crystal Icenhour, PhD, has announced a special E-Sphere® Stool DNA Extraction Kit Evaluation Program.
“We want to give potential customers an opportunity to gain first-hand experience with our extraction kit and our Simply Molecular® technology and we’re interested in their feedback. This Evaluation Program includes a quick survey we ask participants to complete and it provides a free Evaluation Kit (one kit with 10 extractions), a 50% discount on the retail price of Validation Kit (up to 3 kits with 50 extractions each), and a 30% discount on their first order of any quantity after completion of the Validation. Our technologists are also on hand to provide technical support, when needed.”
Infectious disease is the fourth most common cause of death in the United States and the leading cause worldwide.
Recent news headlines have demonstrated the impact of water and food-borne illness - whether from contaminated vegetables in cosmopolitan cities or unclean rural water sources in developing or ravaged countries.
Rapid and specific diagnosis not only provides better outcomes for patients, but can also play an important role in resolving epidemic crises. Phthisis Diagnostics products have the potential to play a key role in improving health care while also saving on health care costs.
Phthisis will return to Grapevine, Texas, November 17-19 for the annual meeting and exhibition of the Association for Molecular Pathology (AMP 2011) and will exhibit in a series of State Fall Meetings of the South Central Association for Clinical Microbiology (Flatwoods, West Virginia on September 30; Bardstown, Kentucky on October 14; Plainfield, Indiana on October 17; Howell, Michigan on October 27; and Columbus, Ohio on October 31).